KELLI WHITTEN: Open Payments
NPI 1780922096 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 23 payments from 12 companies in 2025. Trend: 2023 $142 · 2024 $547 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $121 |
| AstraZeneca Pharmaceuticals LP | 3 | $86 |
| JAZZ PHARMACEUTICALS INC. | 2 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| Daiichi Sankyo Inc. | 2 | $56 |
| PFIZER INC. | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| ARRAY BIOPHARMA INC | 1 | $29 |
| Genentech USA, Inc. | 1 | $26 |
| Celgene Corporation | 1 | $24 |
Products named: TECVAYLI, ZEPZELCA, PLUVICTO, CALQUENCE, LYNPARZA, ERLEADA, DATROWAY, XALKORI.
Industry payments across TX — which companies pay providers there.
